| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |